Assess the Risk: GIST

  • Assess the Risk: GIST
  • Assess the Risk: GIST

Detailed App Info:

  • Last Changed:Time:
  • Current Version:Version: 1.0
  • Device Type:Device: iOS Universal
  • Category:Category: Medical
  • iTunes Seller:Seller:
  • Download Size:App Size: 1.77 MB

Application Description

Twitter:
Google:
Facebook:
An interactive activity designed for use on an iPad, this program estimates the risk of recurrence in gastrointestinal stromal tumor (GIST)—a GI cancer—using various assessment methodologies. The application features 4 hypothetical GIST patients and allows you to select input for key tumor-related prognostic factors. The recurrence risk is then calculated utilizing 3 risk assessment tools, which were developed in conjunction with government institutes and major cancer organizations. It is intended as an educational exercise for use by oncologists and other healthcare professionals who are involved in the evaluation of patients after resection of a primary GIST. Information is presented for educational purposes only. Results not intended for use in treatment decisions. This easy-to-use application underscores not only the importance of assessing the risk of recurrence, but also how the estimated risk is influenced by various prognostic factors, as well as the selected assessment approach.

Requirements

Your mobile device must have at least 1.77 MB of space to download and install Assess the Risk: GIST app. Assess the Risk: GIST is available on iTunes for $0.00

If you have any problems with installation or in-app purchase, found bugs, questions, comments about this application, you can visit the official website of Novartis Pharmaceutical Corporation at http://www.novartisoncology.com/index.jsp.

Copyright © Novartis Pharmaceuticals Corporation